A single-site, open-label, three-panel pharmacokinetics, safety and tolerability study of anacetrapib in healthy Chinese subjects
Latest Information Update: 15 Jun 2021
At a glance
- Drugs Anacetrapib (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions; Pharmacokinetics
- 15 Jun 2021 New trial record
- 08 Jun 2021 Results published in the Advances in Therapy.